The Next Frontier for Clinical Trials: Your Neighborhood

This Event has Passed

Where

Virtual

When

{{getUserDateTimezone("1733767200").singleDate}}
{{getUserDateTimezone("1733767200").time}} - {{getUserDateTimezone("1733770800").time}} {{getClientTimezoneName()}}

About

We all know the assignment: make it easier for people to volunteer for clinical trials, make sure these crucial studies represent the diversity of the real world, and, when possible, let patients lead the way. But how do we accomplish this? Join us for a look at what policy changes could make a powerful idea—the decentralized clinical trial—the standard of practice.

Sponsor Introduction

Janelle Sabo, PharmD, RPh, MBA, senior vice president, clinical capabilities, Eli Lilly & Co.

Featured Speakers

Michael “Micky” Cohen-Wolkowiez, M.D. Ph.D., Kiser-Arena Distinguished Professor of Pediatrics at Duke University and executive director of the DCRI i-Cubed Center; member, Duke Clinical Research Institute
Brad Hirsch, M.D., co-founder, Highlander Health
Michelle McMurry-Heath, M.D., Ph.D., CEO, BioTechquity Clinical
Leonard Sacks, M.D., associate director for clinical methodology, CDER, FDA
Lizzy Lawrence, FDA reporter, STAT (moderator)